Early SGLT2 Inhibitor Initiation in Acute Heart Failure: Moving from Therapeutic Delay to Selective Early Implementation

Binyamin Ben Avraham, Tuvia Ben Gal, Linda W van Laake; Early SGLT2 Inhibitor Initiation in Acute Heart Failure: Moving from Therapeutic Delay to Selective

Authors

Institutions

Publication Details

Journal
European Journal of Heart Failure
Published
2026-08-27
DOI
https://doi.org/10.1093/ejhf/xuag279
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early SGLT2 Inhibitor Initiation in Acute Heart Failure: Moving from Therapeutic Delay to Selective Early Implementation

Binyamin Ben Avraham, Tuvia Ben‐Gal, Linda W van Laake
European Journal of Heart Failure
Diabetes Treatment and Management
article

Early SGLT2 Inhibitor Initiation in Acute Heart Failure: Moving from Therapeutic Delay to Selective Early Implementation

Binyamin Ben Avraham, Tuvia Ben‐Gal, Linda W van Laake
article en

Abstract

Binyamin Ben Avraham, Tuvia Ben Gal, Linda W van Laake; Early SGLT2 Inhibitor Initiation in Acute Heart Failure: Moving from Therapeutic Delay to Selective

European Journal of Heart Failure
Tel Aviv University (IL), Rabin Medical Center (IL), University Medical Center Utrecht (NL)
Good health and well-being
Openalex Percentile: Top 10%
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.